Sevara^®

Sorafenib

Product Information

Proprietary Name: Sevara®
Generic Name: Sorafenib
Dosage Form: Film-coated Tablet
Strengths: 200 mg
Indications: Hepatocellular Carcinoma, Renal Cell Carcinoma, Differentiated Thyroid Carcinoma

Download Leaflet

Oncology

Sevara®

Sorafenib is indicated for the treatment of hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid carcinoma.

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Products

Support

Company

Follow Us

© NanoAlvand. All rights reserved. Powered by ِDGN.